ONC — Oncolytics Biotech Share News
0.000.00%
Last trade - 00:00- CA$138.32m
- CA$123.56m
Brief: Oncolytics Biotech Inc Files For Mixed Shelf Of Up To C$150 Million – SEC Filing
Brief: Oncolytics Biotech Presents Clinical Proof-Of-Concept Data In Multiple Myeloma At ASCO Virtual Annual Meeting
Brief: Oncolytics Biotech Presents Clinical Proof-Of-Concept Data In Multiple Myeloma At The ASCO Virtual Annual Meeting
Brief: Oncolytics Biotech Presents Clinical Data Supporting A Predictive Biomarker Of Pelareorep Response In Breast Cancer At Esmo Breast Cancer Virtual Meeting
Brief: Oncolytics Biotech® Announces Publication Of Abstracts At The 2020 ASCO Virtual Annual Meeting
Canada Research Roundup: Artis REIT, Constellation Software, SNC-Lavalin Group
Brief: Oncolytics Biotech Reports Quarterly Diluted Loss Per Share Were $0.04
Brief: Oncolytics Biotech Announces Publication Of Pelareorep's Clinical Benefit
Brief: Oncolytics Biotech® Announces Favourable Aware-1 Safety Update
Brief: Oncolytics Biotech Reports Net Loss For Q4 Was $19.4 Mln
Brief: Oncolytics Biotech Announces Data Identifying CEACAM6 As A Prospective Biomarker For Pelareorep In The Treatment Of Pancreatic Adenocarcinoma
U.S. STOCKS ON THE MOVE-Alibaba, Tesla, BlackRock
U.S. STOCKS ON THE MOVE-Avon Products, Sina Corp, Core Laboratories, Halliburton
U.S. STOCKS ON THE MOVE-Uber, Dick's Sporting, Tencent, Schlumberger
Oncolytics Biotech: Slumps to record low after offering priced
Brief: Oncolytics Biotech Says Pricing Of Offering Of 4.6 Mln Common Shares And Warrants At Price Of $0.81 Per Share & Warrant
Oncolytics Biotech: Falls after wider loss, stock and warrants offering
Brief: Oncolytics Biotech Announces Underwritten Public Offering
Brief: Oncolytics Biotech Inc Qtrly Loss Per Share $0.26